Johns Hopkins ABX Guide
Sparfloxacin
INDICATIONS
FDA
FDA
- No longer available in the U.S.
- Community-acquired pneumonia (CAP)
- Acute bacterial exacerbations of chronic bronchitis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Mycobacterial infections
- Urinary tract infections
- Gonococcal infections
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: December 6, 2020
Citation
Avdic, Edina. "Sparfloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2020. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540511/all/Sparfloxacin.
Avdic E. Sparfloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540511/all/Sparfloxacin. Accessed December 18, 2024.
Avdic, E. (2020). Sparfloxacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540511/all/Sparfloxacin
Avdic E. Sparfloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. [cited 2024 December 18]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540511/all/Sparfloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sparfloxacin
ID - 540511
A1 - Avdic,Edina,Pharm.D.
Y1 - 2020/12/06/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540511/all/Sparfloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
